- Published at
- by benzinga.com
positive
positive
Melt Pharmaceuticals Completes Phase 1 Study for Sublingual, Non-Opioid Pain and Sedation Drug Candidate
BOSTON, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing first-in-class medicines for ...